Browse by Changes

Additions

Addition – Item

10211K MIFEPRISTONE (&) MISOPROSTOL, mifepristone 200 mg tablet [1] (&) misoprostol 200 microgram tablet [4], 1 pack (MS-2 Step)
10210J PNEUMOCOCCAL PURIFIED CAPSULAR POLYSACCHARIDES, pneumococcal purified capsular polysaccharides 25 microgram/0.5 mL injection, 1 x 0.5 mL syringe (Pneumovax 23)

Addition – Brand

8179L Anastrozole FBM, FOANASTROZOLE, anastrozole 1 mg tablet, 30
2729P Chem mart Baclofen, CHBACLOFEN, baclofen 10 mg tablet, 100
2729P GenRx Baclofen, GXBACLOFEN, baclofen 10 mg tablet, 100
2729P Terry White Chemists Baclofen, TWBACLOFEN, baclofen 10 mg tablet, 100
2730Q Chem mart Baclofen, CHBACLOFEN, baclofen 25 mg tablet, 100
2730Q GenRx Baclofen, GXBACLOFEN, baclofen 25 mg tablet, 100
9296G Clopidogrel/Aspirin Actavis 75/100, GNCLOPIDOGREL + ASPIRIN, clopidogrel 75 mg + aspirin 100 mg tablet, 30
8532C Odaplix SR, AFINDAPAMIDE, indapamide hemihydrate 1.5 mg tablet: modified release, 90 tablets
8247C Irbesartan Actavis 150, UAIRBESARTAN, irbesartan 150 mg tablet, 30
8405J Irbesartan HCT Actavis 300/12.5, UAIRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30
3064G Dulose, FMLACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1
9331D Lansoprazole ODT GH, GQLANSOPRAZOLE, lansoprazole 15 mg tablet: orally disintegrating, 28 tablets
9477T Lansoprazole ODT GH, GQLANSOPRAZOLE, lansoprazole 30 mg tablet: orally disintegrating, 28 tablets
8245Y Letrozole FBM, FOLETROZOLE, letrozole 2.5 mg tablet, 30
1818Q Methotrexate MYX, YNMETHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1
1324Q APO-Metoprolol, TXMETOPROLOL TARTRATE, METOPROLOL TARTRATE Tablet 50 mg, 100
1325R APO-Metoprolol, TXMETOPROLOL TARTRATE, METOPROLOL TARTRATE Tablet 100 mg, 60

 

Deletions

Deletion – Item

2095G TICLOPIDINE, ticlopidine hydrochloride 250 mg tablet, 60 (Tilodene)

Deletion – Brand

2360F Chloromycetin, PFCHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL
5055C Chloromycetin, PFCHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL (Dental)
5512D Chloromycetin, PFCHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL (Optometrical)
2592K GenRx Isotretinoin, GXISOTRETINOIN, isotretinoin 20 mg capsule, 60
2321E Medroxyprogesterone Sandoz, SZMEDROXYPROGESTERONE, medroxyprogesterone acetate 10 mg tablet, 30
8887R Meloxicam Sandoz, SZMELOXICAM, meloxicam 7.5 mg capsule, 30
8888T Meloxicam Sandoz, SZMELOXICAM, meloxicam 15 mg capsule, 30
2430X GenRx Metformin, GXMETFORMIN, metformin hydrochloride 500 mg tablet, 100
1801T GenRx Metformin, GXMETFORMIN, metformin hydrochloride 850 mg tablet, 60
8456C Sequase, PMQUETIAPINE, quetiapine 25 mg tablet, 60
8457D Sequase, PMQUETIAPINE, quetiapine 100 mg tablet, 90
8458E Sequase, PMQUETIAPINE, quetiapine 200 mg tablet, 60
8580N Sequase, PMQUETIAPINE, quetiapine 300 mg tablet, 60

 

Advance Notices

1 March 2015

Deletion – Item
8849R ESCITALOPRAM, escitalopram 10 mg/mL oral liquid, 28 mL
Deletion – Brand
5006L AMOXYCILLIN + CLAVULANIC ACID, amoxycillin 875 mg + clavulanic acid 125 mg tablet, 10 (GenRx Amoxycillin and Clavulanic Acid)
8254K AMOXYCILLIN + CLAVULANIC ACID, amoxycillin 875 mg + clavulanic acid 125 mg tablet, 10 (GenRx Amoxycillin and Clavulanic Acid)
2964B CEPHALOTHIN, cephalothin 1 g injection, 10 x 1 g vials, (Cefalotin Sandoz)
3376Q CEPHALOTHIN, cephalothin 1 g injection, 10 x 1 g vials, (Cefalotin Sandoz)
1245M LEVODOPA + CARBIDOPA ANHYDROUS, levodopa 250 mg + carbidopa anhydrous 25 mg tablet, 100, (Levo/Carbidopa Sandoz)
2681D POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte)
5525T POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte)
9222J POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL, (PVA Forte)

1 April 2015

Deletion – Item
2710P MIFEPRISTONE, mifepristone 200 mg tablet, 1
2672P MISOPROSTOL, misoprostol 200 microgram tablet, 4

1 May 2015

Deletion – Item
2995P SALCATONIN, salcatonin 50 international units/mL injection, 5 x 1 mL ampoules

9004X

TESTOSTERONE UNDECANOATE, testosterone undecanoate 1 g/4 mL injection, 1 x 4 mL ampoule

 

Prescriber Bag

Addition – Item

10209H LIGNOCAINE, lignocaine hydrochloride anhydrous 1% (50 mg/5 mL) injection, 5 x 5 mL ampoules (Pfizer Australia Pty Ltd)

 

Palliative Care

Addition – Brand

5387M Dulose, FMLACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1
5388N Dulose, FMLACTULOSE, LACTULOSE Mixture 3.34 g per 5 mL, 500 mL, 1

Deletion – Item

5333Q CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae)
5335T CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae)
5334R CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae)
5336W CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae)
5421H HYPROMELLOSE, HYPROMELLOSE Oral gel 20 mg per g, 100 g, 1 (Aquae Gel)
5422J HYPROMELLOSE, HYPROMELLOSE Oral gel 20 mg per g, 100 g, 1 (Aquae Gel)

 

Highly Specialised Drugs Program (Public Hospital)

Deletion – Item

5620T CIDOFOVIR, cidofovir 375 mg/5 mL injection, 1 x 5 mL vial (Vistide)

 

Highly Specialised Drugs Program (Private Hospital)

Deletion – Item

6247T CIDOFOVIR, cidofovir 375 mg/5 mL injection, 1 x 5 mL vial (Vistide)

 

Efficient Funding of Chemotherapy (Public Hospital)

Addition – Brand

4451G Irinotecan MYX, YNIRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial
4502Y Methotrexate MYX, YNMETHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1
4512L Methotrexate MYX, YNMETHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1
4502Y Methotrexate MYX, YNMETHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial
4512L Methotrexate MYX, YNMETHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial
4542C Oxaliplatin MYX, YNOXALIPLATIN, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial

Changes to Restrictions

The following items have additions, deletions or alterations to restrictions and/or notes.

4371C ARSENIC,
arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen)
4312Y CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
4435K CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
4364Q DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL,
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN)
4600D PEMETREXED,
pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta);
pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta)

 

Efficient Funding of Chemotherapy (Private Hospital)

Addition – Brand

7249M Irinotecan MYX, YNIRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial
7250N Methotrexate MYX, YNMETHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1
7251P Methotrexate MYX, YNMETHOTREXATE, METHOTREXATE Injection 50 mg in 2 mL, 1
7250N Methotrexate MYX, YNMETHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial
7251P Methotrexate MYX, YNMETHOTREXATE, methotrexate 1 g/10 mL injection, 1 x 10 mL vial
7253R Oxaliplatin MYX, YNOXALIPLATIN, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial

Changes to Restrictions

The following items have additions, deletions or alterations to restrictions and/or notes.

7241D ARSENIC,
arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen)
10114H BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
10120P BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
7243F BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
7236W CABAZITAXEL,
CABAZITAXEL Jevtana Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent, 1 (Jevtana)
7223E CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
7240C CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
7242E CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
7273T CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
7230M DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL,
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN)
2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy)
2643D IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy)
10069Y PANITUMUMAB,
panitumumab 400 mg/20 mL injection, 1 x 20 mL vial (Vectibix);
panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix)
7255W PEMETREXED,
pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta);
pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta)
10193L RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
7257Y RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
7258B RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
7259C RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)

Alteration – Restriction Level

From To
7241D ARSENIC,
arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL vials (Phenasen)
authority-required streamlined
10114H BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
authority-required streamlined
10120P BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
authority-required streamlined
7243F BEVACIZUMAB,
bevacizumab 100 mg/4 mL injection, 1 x 4 mL vial (Avastin);
bevacizumab 400 mg/16 mL injection, 1 x 16 mL vial (Avastin)
authority-required streamlined
7236W CABAZITAXEL,
CABAZITAXEL Jevtana Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent, 1 (Jevtana)
authority-required streamlined
7223E CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
authority-required streamlined
7240C CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
authority-required streamlined
7242E CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
authority-required streamlined
7273T CETUXIMAB,
cetuximab 100 mg/20 mL injection, 1 x 20 mL vial (Erbitux);
cetuximab 500 mg/100 mL injection, 1 x 100 mL vial (Erbitux)
authority-required streamlined
7230M DOXORUBICIN HYDROCHLORIDE-PEGYLATED LIPOSOMAL,
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx);
doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Liposomal Doxorubicin SUN);
doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial (Liposomal Doxorubicin SUN)
authority-required streamlined
2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy)
authority-required streamlined
2643D IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 1 x 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 1 x 40 mL vial (Yervoy)
authority-required streamlined
10069Y PANITUMUMAB,
panitumumab 400 mg/20 mL injection, 1 x 20 mL vial (Vectibix);
panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix)
authority-required streamlined
7255W PEMETREXED,
pemetrexed 500 mg injection, 1 x 500 mg vial (Alimta);
pemetrexed 100 mg injection, 1 x 100 mg vial (Alimta)
authority-required streamlined
10193L RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
authority-required streamlined
7257Y RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
authority-required streamlined
7258B RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
authority-required streamlined
7259C RITUXIMAB,
rituximab 100 mg/10 mL injection, 2 x 10 mL vials (Mabthera);
rituximab 500 mg/50 mL injection, 1 x 50 mL vial (Mabthera)
authority-required streamlined

 

Repatriation Pharmaceutical Benefits

Addition – Brand

4307Q Sunsense Sensitive SPF 50+, EOSUNSCREENS, SUNSCREENS Cream 75 g, 1
4546G Sunsense Ultra SPF 50+, EOSUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1

Deletion – Item

4568K CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 25 mL (Aquae)
4569L CARMELLOSE SODIUM, carmellose sodium 10 mg/mL oral spray, 100 mL (Aquae)

Deletion – Brand

4307Q Sunsense Sensitive SPF 30+, EOSUNSCREENS, SUNSCREENS Cream 75 g, 1
4546G Hamilton Sunscreen Family Sunscreen Milk SPF 15, KYSUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1
4546G SunSense Ultra SPF 30+, EOSUNSCREENS, SUNSCREENS Lotion (non-alcoholic) 125 mL, 1

Alteration – Manufacturer Code

From To
4328T ColofacMEBEVERINE, mebeverine hydrochloride 135 mg tablet, 90 AB GO
4396J HytrinTERAZOSIN, terazosin 1 mg tablet [7 tablets] (&) terazosin 2 mg tablet [7 tablets], 14 AB GO
4397K HytrinTERAZOSIN, terazosin 2 mg tablet, 28 AB GO
4398L HytrinTERAZOSIN, terazosin 5 mg tablet, 28 AB GO
4399M HytrinTERAZOSIN, terazosin 10 mg tablet, 28 AB GO